| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |